Literature DB >> 18976374

Classification of atopic hand eczema and the filaggrin mutations.

Charlotte Giwercman1, Anne Lerbaek, Hans Bisgaard, Torkil Menné.   

Abstract

Hand eczema is a common disease with various risk factors of which atopic dermatitis is known to be one of the most important. Recently, two mutations in the gene coding for filaggrin, a protein important for the skin barrier, have repeatedly been shown to be associated with atopic dermatitis. Moreover, one study point towards an association between the filaggrin null alleles and the subgroup of patients having both hand eczema and atopic dermatitis. For the remainder of hand eczema patients, still unknown genetic risk factors exist. We propose that in future, classification of atopic hand eczema should distinguish between patients with and without the filaggrin null alleles and to further differentiate between associations with type I allergy, type IV allergy and exposure to irritants, respectively. Furthermore, we suggest future studies of atopic hand eczema to analyse for the filaggrin mutations. We believe this will increase the possibility of subgrouping this otherwise heterogenic disease and thereby enable a better phenotype-genotype characterization of hand eczema. This could improve the preventive initiatives, secure better information of patients about the prognosis for their disease, and possibly enable targeted treatment.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18976374     DOI: 10.1111/j.1600-0536.2008.01426.x

Source DB:  PubMed          Journal:  Contact Dermatitis        ISSN: 0105-1873            Impact factor:   6.600


  5 in total

1.  Reduced inflammatory threshold indicates skin barrier defect in transglutaminase 3 knockout mice.

Authors:  Peter Bognar; Ilona Nemeth; Balazs Mayer; Dora Haluszka; Norbert Wikonkal; Eszter Ostorhazi; Susan John; Mats Paulsson; Neil Smyth; Maria Pasztoi; Edit I Buzas; Robert Szipocs; Attila Kolonics; Erzsebet Temesvari; Sarolta Karpati
Journal:  J Invest Dermatol       Date:  2013-07-24       Impact factor: 8.551

2.  Acute Pustular Dermatosis, Following Topical Treatment With Pimecrolimus, in a Child Affected With Atopic and Contact Hand Dermatitis.

Authors:  Dimitri Poddighe; Valeria Brazzelli; Amelia Licari; Gian Luigi Marseglia
Journal:  J Pediatr Pharmacol Ther       Date:  2016 Jan-Feb

3.  Deep phenotyping of the unselected COPSAC2010 birth cohort study.

Authors:  H Bisgaard; N H Vissing; C G Carson; A L Bischoff; N V Følsgaard; E Kreiner-Møller; B L K Chawes; J Stokholm; L Pedersen; E Bjarnadóttir; A H Thysen; E Nilsson; L J Mortensen; S F Olsen; S Schjørring; K A Krogfelt; L Lauritzen; S Brix; K Bønnelykke
Journal:  Clin Exp Allergy       Date:  2013-12       Impact factor: 5.018

4.  Chronic Hand Eczema Guidelines From an Expert Panel of the International Eczema Council.

Authors:  Jonathan I Silverberg; Emma Guttman-Yassky; Tove Agner; Robert Bissonnette; David E Cohen; Eric Simpson; Andreas Wollenberg; Jacob P Thyssen
Journal:  Dermatitis       Date:  2021 Sep-Oct 01       Impact factor: 4.845

5.  Comparison of ALitretinoin with PUVA as the first-line treatment in patients with severe chronic HAnd eczema (ALPHA): study protocol for a randomised controlled trial.

Authors:  Isabelle L Smith; Rachael Gilberts; Sarah Brown; Catherine Fernandez; Jane Nixon; Catherine Reynolds; Catherine Smith; John T Lear; Lesley Sunderland; Cathy Green; Mark Goodfield; Fiona Cowdell; Philip Hampton; Amy Barker; Armando Vargas-Palacios; Sandy Tubeuf; Miriam Wittmann
Journal:  BMJ Open       Date:  2022-02-23       Impact factor: 2.692

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.